Axsome Therapeutics (AXSM) Tax Provisions (2017 - 2026)

Axsome Therapeutics has reported Tax Provisions for 5 years, with the latest figure at $502000.0 in Q4 2025.

• Quarterly Tax Provisions rose 490.59% year-over-year to $502000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$458000.0 (down 638.82% YoY) and the FY2025 annual result came in at -$498000.0, down 685.88% from the prior year.
• Tax Provisions advanced to $502000.0 in Q4 2025 per AXSM's latest filing, from -$960000.0 in the prior quarter.
• Over five years, Tax Provisions peaked at $2.6 million in Q1 2023 and troughed at -$960000.0 in Q2 2025.
• A 3-year average of $87000.0 and a median of -$340000.0 in 2023 frame the typical range for Tax Provisions.
• The sharpest annual moves came in 2024 and 2025: Tax Provisions surged 125.0% in 2024, then jumped 490.59% in 2025.
• Over 3 years, Tax Provisions stood at -$340000.0 in 2023, then soared by 125.0% to $85000.0 in 2024, then surged by 490.59% to $502000.0 in 2025.
• According to Business Quant data, Tax Provisions over the past three periods registered $502000.0, -$960000.0, and $85000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.